Please login to the form below

Neupogen

This page shows the latest Neupogen news and features for those working in and with pharma, biotech and healthcare.

Novartis doubles down on biosimilars with Biocon alliance

Previous launches have included its Glatopa version of Teva’s multiple sclerosis drug Copaxone (glatiramer acetate) and Zarxio, a variant of Amgen’s Neupogen (filgrastim).

Latest news

Novartis takes biosimilar delay complaint to Supreme Court

Novartis is appealing an earlier ruling which ordered the company to delay launch of Zarxio, its version of Amgen's white blood cell stimulator Neupogen (filgrastim) and the first biosimilar to
Novartis claims first place for its biosimilar Enbrel in US

biosimilars business after the company got a green light for its Zarxio copy of Amgen's neutropenia therapy Neupogen (filgrastim).
Novartis gets FDA panel backing for biosimilar Enbrel

The GP2015 recommendation also puts Novartis on course for a second biosimilar approval in the US after its Zarxio product, a copy of Amgen's white blood cell stimulator Neupogen (filgrastim)
Sandoz files for approval of Neulasta biosimilar in Europe

The generic drug specialist - which also sells a biosimilar version of Amgen's short-acting GCSF product Neupogen (filgrastim) - said the Neulasta filing means it is now halfway to its objective
FDA panel recommends first biosimilar antibody for approval

The drug is also only the second biosimilar to be approved in the US after Novartis/Sandoz' Zarxio (filgrastim-sndz), which is a copy of Amgen's white cell stimulator Neupogen

More from news
Approximately 8 fully matching, plus 34 partially matching documents found.

Latest Intelligence

Customer experience rules the digital age

Establishing an effective customer journey
Embracing digital disruption in pharma

LEO Innovation Lab and some of its successes to date
Biosimilars - the same, but different?

Neupogen (filgrastim).

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

AP Pharma appoints Dendreon’s Jesse Hollingsworth to lead sales

This was preceded by a period as marketing director for the oncology business unit of Amgen, where he worked on such products as Neulasta, Neupogen and Vectibix.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Account Manager / Senior Account Manager: 35, 000-40, 000

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

SAM – Health Behaviour/ Patient Adherence Healthcare Agency: Salary TBC

Account Manager, Healthcare Public Affairs: £32, 000 – £40, 000 benefits

Senior Account Director development role to Business Director, H...: Excellent package

Medical Writers: Competitive Salary and Benefits

Medical/ Scientific Director: Salary TBC

Account Manager / Account Director: Competative

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Scientific Director / Editorial Team Leader: Great salary and benefits

Account Manager – Creative Healthcare Advertising – Central Lond...: Salary TBC

Project / Account Manager (Medical Education): Salary TBC

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Account Director - Healthcare Advertising - London - HOME WORKIN...: £50000 - £68000

Senior Account Executive, London, Medical Communications: Excellent package

Director, Market Access / HEOR - North-West: Negotiable

Senior Systematic Review Analyst - Oxford: Negotiable

Events Manager – Med Comms – Surrey: Salary TBC

Production Manager – Healthcare Communications: DOE

Client Services Director – Medical Education Agency – North West...: Salary TBC

Senior Medical Writer: Competitive Salary

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Associate Director, Market Access & HEOR – North-West: Negotiable

Programme Director, Healthcare PR, Highly competitive package: Highly Competitive package

Subscribe to our email news alerts

PMHub

Add my company

Complete Medical Communications (CMC)

CMC is a leading global agency dedicated to healthcare communications across the lifecycle. We combine scientific acumen, excellence in delivery...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award: The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare: Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer: Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...